Pentostatin in T-cell malignancies – a phase II trial of the EORTC

This publication has 39 references indexed in Scilit:

• Classification of peripheral t-cell lymphomas: cytogenetic findings support the updated kiel classification
  Leukemia & Lymphoma, 1996
• Peripheral T‐cell non‐Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T‐zone lymphoma
  British Journal of Haematology, 1994
• Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group
  JNCI Journal of the National Cancer Institute, 1993
• 2-Chlorodeoxyadenosine: A New Nucleoside Agent Effective in the Treatment of Lymphoid Malignancies
  Leukemia & Lymphoma, 1993
• Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer
  JNCI Journal of the National Cancer Institute, 1990
• Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group Study
  JNCI Journal of the National Cancer Institute, 1990
• 2′ deoxycoformycin (pentostatin) for refractory non‐Hodgkin's lymphoma: A calgb phase II study
  Medical and Pediatric Oncology, 1990
• THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA
  The Lancet, 1981
• REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA
  The Lancet, 1980
• ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
  The Lancet, 1972